Upal Roy

2.6k total citations · 1 hit paper
75 papers, 1.8k citations indexed

About

Upal Roy is a scholar working on Virology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Upal Roy has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 17 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Upal Roy's work include HIV Research and Treatment (21 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer Genomics and Diagnostics (9 papers). Upal Roy is often cited by papers focused on HIV Research and Treatment (21 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer Genomics and Diagnostics (9 papers). Upal Roy collaborates with scholars based in United States, India and Japan. Upal Roy's co-authors include Santosh Kumar Dubey, Debasis Mondal, Howard E. Gendelman, JoEllyn McMillan, Madhavan Nair, Shantanu Balkundi, Amit Alexander, Hafiz Ahmed, Mukta Agrawal and A Prabakaran and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cell and PLoS ONE.

In The Last Decade

Upal Roy

70 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PCL-PEG copolymer based injectable thermosensitive hydrogels

2022 172 citations A Prabakaran, Upal Roy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Upal Roy United States	23	514	461	361	236	213	75	1.8k
Luigia Rossi Italy	31	1.0k 2.0×	262 0.6×	292 0.8×	383 1.6×	576 2.7×	119	2.8k
J.‐H. Saurat Switzerland	36	715 1.4×	194 0.4×	301 0.8×	37 0.2×	96 0.5×	131	3.5k
Oliver Flint United States	23	901 1.8×	197 0.4×	207 0.6×	45 0.2×	260 1.2×	85	2.1k
Rachael M. Crist United States	21	867 1.7×	235 0.5×	146 0.4×	618 2.6×	562 2.6×	31	2.3k
Nancy P. Y. Chung United States	16	410 0.8×	191 0.4×	166 0.5×	40 0.2×	113 0.5×	24	1.4k
Huanhuan Cui China	29	728 1.4×	70 0.2×	48 0.1×	144 0.6×	87 0.4×	90	2.4k
Yi Zeng China	26	1.0k 2.0×	125 0.3×	316 0.9×	283 1.2×	246 1.2×	78	2.9k
José Antonio Lebrón Spain	18	745 1.4×	58 0.1×	141 0.4×	195 0.8×	135 0.6×	55	3.0k
Hitendra S. Chand United States	25	719 1.4×	38 0.1×	373 1.0×	82 0.3×	120 0.6×	66	2.1k
Margaret Liu United States	27	983 1.9×	54 0.1×	186 0.5×	150 0.6×	323 1.5×	107	2.4k

Countries citing papers authored by Upal Roy

Since Specialization

Citations

This map shows the geographic impact of Upal Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Upal Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Upal Roy more than expected).

Fields of papers citing papers by Upal Roy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Upal Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Upal Roy. The network helps show where Upal Roy may publish in the future.

Co-authorship network of co-authors of Upal Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Upal Roy. A scholar is included among the top collaborators of Upal Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Upal Roy. Upal Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jang, Jinhyeong, et al.. (2025). Nanodiamonds in Advancing Biomedical Sciences. ACS Applied Materials & Interfaces. 17(52). 70311–70334.

Vaiphei, Klaudi K., A Prabakaran, Shikha Snigdha, et al.. (2024). Impact of PEGylated liposomes on cytotoxicity of tamoxifen and piperine on MCF-7 human breast carcinoma cells. Journal of Drug Delivery Science and Technology. 102(Pt A). 106331–106331. 3 indexed citations

Kamkwalala, Asante R., Ankita Garg, Upal Roy, et al.. (2024). The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive Performance in People With HIV. Clinical Infectious Diseases. 80(4). 871–880. 2 indexed citations

Das, Ranjit Kumar, Omar M. Benavides, Alejandro López‐Juárez, et al.. (2024). Enriched Environment Contributes to the Recovery from Neurotoxin-Induced Parkinson’s Disease Pathology. Molecular Neurobiology. 61(9). 6734–6753. 2 indexed citations

Roy, Upal, et al.. (2023). Plain language summary of 2022 cancer statistics: Focus on lung cancer. Future Oncology. 21(27). 3447–3457. 25 indexed citations

Rad, Armin Tahmasbi, et al.. (2022). Effect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection. Nanomedicine. 17(13). 959–978. 11 indexed citations

Magnuson, Allison, Suanna S. Bruinooge, Harpreet Singh, et al.. (2021). Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group. Clinical Cancer Research. 27(9). 2424–2429. 44 indexed citations

Kamkwalala, Asante R., Ankita Garg, Upal Roy, et al.. (2021). Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop. AIDS Research and Human Retroviruses. 37(11). 807–820. 3 indexed citations

Smeltzer, Matthew P., Paul A. Bunn, Upal Roy, et al.. (2021). PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials. Journal of Thoracic Oncology. 16(10). S847–S848. 3 indexed citations

10.

Arnalich, Francisco, et al.. (2019). The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley. Current HIV Research. 17(6). 377–387. 4 indexed citations

11.

Gerlach, Samantha L., Partha K. Chandra, Upal Roy, et al.. (2019). The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral Drugs. SHILAP Revista de lepidopterología. 6(1). 33–33. 22 indexed citations

12.

Roy, Upal, Margaret M. Byrne, J. McCoy, Courtney Blair, & Jamie L. Studts. (2019). P2.11-32 Project ACTS (Adherence to CT Screening): Developing Patient Engagement Tools to Support Lung Cancer Screening Adherence. Journal of Thoracic Oncology. 14(10). S805–S806. 1 indexed citations

13.

Roy, Upal, et al.. (2018). MA07.09 Willingness to Perform Multiple Biopsies to Improve Quality of Lung Cancer Care: Understanding the Oncologists’ Perspective. Journal of Thoracic Oncology. 13(10). S380–S380. 3 indexed citations

14.

Bonomi, Philip, Gideon M. Blumenthal, Andrea Stern Ferris, et al.. (2018). Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria. Journal of Thoracic Oncology. 13(6). 748–751. 10 indexed citations

15.

Roy, Upal, et al.. (2017). OA16.06 Willingness for Multiple Biopsies to Improve Quality of Lung Cancer Care: Understanding the Patient Perspective. Journal of Thoracic Oncology. 12(1). S306–S307. 1 indexed citations

16.

Huang, Zhifeng, William M. Marsiglia, Upal Roy, et al.. (2015). Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ. Molecular Cell. 61(1). 98–110. 42 indexed citations

17.

Roy, Upal, et al.. (2013). Specific Increase in MDR1 Mediated Drug-Efflux in Human Brain Endothelial Cells following Co-Exposure to HIV-1 and Saquinavir. PLoS ONE. 8(10). e75374–e75374. 18 indexed citations

18.

Roy, Upal, Geetika Chakravarty, Kerstin Höner zu Bentrup, & Debasis Mondal. (2009). Montelukast Is a Potent and Durable Inhibitor of Multidrug Resistance Protein 2-Mediated Efflux of Taxol and Saquinavir. Biological and Pharmaceutical Bulletin. 32(12). 2002–2009. 20 indexed citations

19.

Roy, Upal, et al.. (2006). Biodiversity of organotin resistant Pseudomonas from west coast of India. Ecotoxicology. 16(2). 253–261. 10 indexed citations

20.

Roy, Upal, Santosh Kumar Dubey, & Shriram G. Bhosle. (2004). Tributyltin chloride-utilizing bacteria from marine ecosystem of west coast of India. Current Science. 86(5). 702–705. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact